KalVista Pharmaceuticals, Inc. (KALV) — Dilution Risk Analysis

Current Snapshot

KalVista Pharmaceuticals, Inc. (KALV) has a DilutionWatch score of 39/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
53,240,888 Source
Public Float
38,180,106 Source
Float as % of Outstanding
71.7%

Dilution Risk Score

Score: 39/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 9, XBRL 1.

FormFiledAccession
4 2026-04-20 0001366244-26-000006
4 2026-04-20 0001815308-26-000003
4 2026-04-20 0001827505-26-000003
4 2026-04-20 0001860131-26-000004
xbrl 2026-04-01 xbrl-3610-xbrl_warrant
4 2026-03-27 0001231919-26-000286
4 2026-03-10 0001366244-26-000005
4 2026-02-24 0001815308-26-000002
4 2026-02-24 0001827505-26-000002
4 2026-02-24 0001691102-26-000002

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 16 months Source
Three-year share count growth 54.75% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 39/10) Source
Cash Runway
16 months Source
Share Count Growth (3-Year)
54.75% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.